CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sigilon Therapeutics, a biopharmaceutical company that discovers and develops Shielded Living Therapeutics, and the Massachusetts Institute of Technology today ...
CAMBRIDGE, Mass. -- MIT biological engineers have developed a new imaging system that allows them to see cells that have undergone a specific mutation. The work, which could help scientists understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback